Yazılar

Sony and Suntory Stockpile Inventory as Japan Faces Potential U.S. Tariff Threat

Japanese companies Sony and Suntory are taking proactive steps to safeguard against potential tariffs imposed by the U.S., building up stockpiles of products in the country. These moves come as President Donald Trump has hinted at further tariffs, specifically targeting Japan, after imposing new trade barriers on Mexico and China—key low-cost production hubs for Japanese industries such as automotive manufacturing.

The ongoing uncertainty regarding U.S. trade policies is exacerbated by Japan’s heavy reliance on exports, particularly to the United States, which has become increasingly vulnerable to tariff measures. The latest potential threat for Japan Inc. has already prompted some companies to adjust production strategies. For instance, Honda has moved some of its production to the U.S., and Japan Display, a major supplier of LCD screens to the automotive sector, is also considering shifting some of its production to the U.S.

Sony, a key player in the electronics and gaming industries, confirmed that it has been preparing for tariffs by stockpiling inventory in the U.S. A similar strategy has been employed by Suntory, a global drinks maker, which shipped tequila from its Mexican brands to the U.S. to avoid tariffs. Suntory is also looking at shifting its sales strategy by selling more American whiskey in the U.S.

Other companies, such as Alps Alpine and Murata Manufacturing, are adjusting their supply chains to avoid the impact of tariffs, with Alps considering moving production back to Japan, while Murata is diversifying its production across China, Japan, and Thailand.

The trade uncertainty has spurred over 300 Japanese companies to consider entering the U.S. market, reflecting growing concerns about tariffs and the shifting trade environment. According to a survey by Japan’s export-promotion agency, many companies are planning to set up U.S. operations to insulate themselves from escalating trade tensions.

GlobalFoundries Projects Weak First Quarter Amid Tariff Concerns and Smartphone Market Weakness

GlobalFoundries, the contract chipmaker based in Malta, New York, issued a bleak forecast for its first-quarter revenue and profit, citing the potential impact of U.S. President Donald Trump’s tariffs on automakers and a struggling smartphone market in 2025. Despite the outlook, the company’s shares reversed earlier losses, rising nearly 4% in morning trading.

For the first quarter, GlobalFoundries expects revenue to range between $1.55 billion and $1.60 billion, below the Wall Street estimate of $1.66 billion, according to data compiled by LSEG. The company also projects adjusted earnings per share to fall between 24 cents and 34 cents, with the midpoint of this range under analysts’ expectations of 32 cents per share.

The automotive sector, which is GlobalFoundries’ third-largest revenue contributor, is especially vulnerable to the effects of tariffs on steel and aluminum imports in the United States. In 2023, the company signed a long-term agreement with General Motors to produce chips exclusively for the carmaker at its Malta facility.

Additionally, GlobalFoundries is facing challenges in its largest segment, smartphones. The global smartphone market is expected to face a turbulent 2025, according to research firm Canalys, further adding pressure on the company’s performance.

For the fourth quarter, GlobalFoundries posted revenue of $1.83 billion, meeting analysts’ estimates. The company also reported a profit of 46 cents per share, excluding items, which was slightly above the expected 44 cents.

Earlier this month, the company announced the appointment of Tim Breen as its new CEO, succeeding Thomas Caulfield.

Siemens Healthineers Shares Rise on Q1 Revenue Beat Despite China Order Delays

Siemens Healthineers (SHLG.DE) reported stronger-than-expected first-quarter revenue on Thursday, with a 5.9% year-on-year increase, despite challenges posed by delayed customer orders in China. The company’s Q1 group revenue reached 5.48 billion euros ($5.69 billion), slightly surpassing the 5.37 billion euros forecast by analysts.

The revenue boost was driven by a 16% surge in U.S. revenues, counteracting a 6% decline in sales from China, which the company attributed to “continued delays in customer orders.” Like many of its peers in the healthcare technology sector, Siemens Healthineers has been impacted by China’s ongoing anti-corruption campaign, leading to reduced hospital equipment orders in the region.

Siemens Healthineers’ Chief Financial Officer, Jochen Schmitz, stated that the company expects continued challenges in China, forecasting a decline in sales in the “medium to high percentage range” during the first half of the year. He also noted a “flat trend” in China’s performance over the following quarters.

Despite the challenges, Siemens Healthineers remains cautiously optimistic, with CEO Bernd Montag emphasizing that while global trade disruptions, such as U.S. tariffs on imports from Mexico and Canada, are a concern, the risk to the healthcare and medical technology sectors remains relatively low. He added that U.S. tariffs on Chinese imports would have a “minor” impact on the company’s business.

The company also expects a stronger U.S. dollar to play a role in its financial outlook. Siemens Healthineers confirmed its full-year guidance, with revenue growth anticipated to fall within the lower end of the projected range of 5% to 6% for the second quarter.